603939 益丰药房
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)11.18114.89115.38315.73913.830
总资产报酬率 ROA (%)4.5325.8676.2526.6265.484
投入资产回报率 ROIC (%)5.3967.0107.6117.9956.469

边际利润分析
销售毛利率 (%)40.40540.12038.20939.52940.346
营业利润率 (%)10.3379.1599.0979.4828.736
息税前利润/营业总收入 (%)10.8939.7939.4029.9689.479
净利润/营业总收入 (%)7.6436.8696.9997.1586.464

收益指标分析
经营活动净收益/利润总额(%)93.47195.68496.763100.03495.722
价值变动净收益/利润总额(%)5.6374.9542.0800.3662.569
营业外收支净额/利润总额(%)-0.952-0.979-0.844-0.429-0.072

偿债能力分析
流动比率 (X)1.4221.2591.0761.0951.174
速动比率 (X)1.0090.8990.7380.7210.723
资产负债率 (%)54.42359.27256.71756.65253.879
带息债务/全部投入资本 (%)39.55444.67039.31638.39433.575
股东权益/带息债务 (%)130.247101.354125.160129.685154.859
股东权益/负债合计 (%)78.77764.68671.62071.77181.429
利息保障倍数 (X)16.66013.55024.64218.91312.647

营运能力分析
应收账款周转天数 (天)28.06431.88431.73326.43822.399
存货周转天数 (天)116.802104.14195.72299.615102.627